Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/18677
Title: Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
Author: Llovet i Bayer, Josep Maria
Mas, X.
Aponte, John J.
Fuster Obregón, Josep
Navasa, Miquel
Christensen, E.
Rodés, J.
Bruix Tudó, Jordi
Keywords: Trasplantament hepàtic
Anàlisi cost-benefici
Càncer de fetge
Hepatic transplantation
Cost effectiveness
Liver cancer
Issue Date: 2002
Publisher: BMJ Group
Note: Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.50.1.123
It is part of: Gut, 2002, vol. 50, núm. 1, p. 123-128
URI: http://hdl.handle.net/2445/18677
ISSN: 0017-5749
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
544216.pdf209.64 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.